1. Review article: recent advances in pharmacogenetics and pharmacokinetics for safe and effective thiopurine therapy in inflammatory bowel disease;Moon;Aliment. Pharmacol. Ther.,2016
2. Thiopurine S-methyltransferase polymorphisms in acute lymphoblastic leukemia, inflammatory bowel disease and autoimmune disorders: influence on treatment response;Abaji;Pharmgenomics. Pers. Med.,2017
3. TPMT polymorphism: when shield becomes weakness;Katara;Interdiscip. Sci. Comput. Life Sci.,2016
4. European Medicines Agency (EMA). Summary of Product Characteristics (SPC). Xaluprine., (n.d.). http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002022/WC500124645.pdf (accessed September 24, 2018).
5. Determination of urinary 6-mercaptopurine and three of its metabolites by HPLC-UV coupled with the iodine-azide reaction;Zakrzewski;Bioanalysis.,2013